EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A sinomenine derivative alleviates bone destruction in collagen-induced arthritis mice by suppressing mitochondrial dysfunction and oxidative stress via the NRF2/HO-1/NQO1 signaling pathway

Wan-Yi Guo, Qi-Min Wu, Hao-Feng Zeng, Yu-Lian Chen, Jie Xu, Zhen-Yi Yu, Yong-Kang Shu, Xiao-Nan Yang, Chuan-Hai Zhang, Xi-Zi He, Jia-Ning Mi, Si Chen und 5 weitere

Pharmacological Research · 2025-05 · 215 · 107686

DOI: 10.1016/j.phrs.2025.107686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacological Research, 2025-05. Verfasst von Wan-Yi Guo und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Traditional Chinese Medicine Syndrome /The Second Clinical College, Guangzhou University of Chinese Medicine, Guangdong Provi…. Hauptthemen laut MEDLINE: Morphinans, Arthritis, Experimental, Mitochondria, Bone Resorption. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone destruction in rheumatoid arthritis (RA) leads to significant disability, yet effective treatments are limited. Sinomenine (Sino) demonstrates anti-arthritic and bone-protective effects but requires high doses. In this study, we developed a Sino derivative, SINX, and evaluated its efficacy in RA. Safety assessments in mice confirmed its suitability for further study. In vitro, SINX inhibited osteoclast differentiation by reducing TRAP-positive cells, disrupting F-actin ring formation, and suppressing bone resorption pits, alongside downregulating osteoclast-specific genes. It also showed strong anti-inflammatory properties by reducing inflammatory cytokine levels. In vivo, using a collagen-induced arthritis (CIA) mouse model, SINX improved bone integrity by reducing joint inflammation, maintaining trabecular bone density, and preventing erosion. Histological and micro-CT analyses confirmed its effects, including suppressed osteoclast activity and reduced bone resorption-related gene expression. Mechanistically, SINX ameliorated mitochondrial dysfunction, decreased ROS levels, and activated the NRF2/HO-1/NQO1 pathway, enhancing antioxidant defenses. Compared to Sino, SINX achieved similar results at lower doses. These findings highlight the potential of SINX as a safe, effective treatment for RA-related bone destruction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MorphinansArthritis, ExperimentalMitochondriaBone ResorptionArthritis, RheumatoidAnti-Inflammatory AgentsAntirheumatic AgentsAnimalsNF-E2-Related Factor 2Oxidative StressSignal TransductionHeme Oxygenase-1MaleMiceMice, Inbred DBAOsteoclastsMembrane Proteins

Stichwörter der Autor:innen

Mitochondrial functionNRF2/HO-1/NQO1Reactive oxygen species (ROS)Rheumatoid arthritisSinomenine derivatives

Substanzen

MorphinansNF-E2-Related Factor 2sinomenineHeme Oxygenase-1Nfe2l2 protein, mouseHmox1 protein, mouseMembrane ProteinsAnti-Inflammatory AgentsAntirheumatic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Traditional Chinese Medicine Syndrome /The Second Clinical College, Guangzhou University of Chinese Medicine, Guangdong Province 510405, China; Chinese Medicine Guangdong Laboratory (Hengqin Labo…
  • State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, China Pharmaceutical University, Jiangning District, Nanjing 211198, China.
  • State Key Laboratory of Traditional Chinese Medicine Syndrome /The Second Clinical College, Guangzhou University of Chinese Medicine, Guangdong Province 510405, China.
  • State Key Laboratory of Quality Research in Chinese Medicine (Macau University of Science and Technology), Taipa, Macao.
  • State Key Laboratory of Traditional Chinese Medicine Syndrome /The Second Clinical College, Guangzhou University of Chinese Medicine, Guangdong Province 510405, China; State Key Laboratory of Quality Research in Chinese…

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Guo, W. Y., Wu, Q. M., Zeng, H. F., Chen, Y. L., Xu, J., Yu, Z. Y., Shu, Y. K., Yang, X. N., Zhang, C. H., He, X. Z., Mi, J. N., Chen, S., Chen, X. M., Wu, J. Q., Yao, H. Q., Liu, L., & Pan, H. D. (2025). A sinomenine derivative alleviates bone destruction in collagen-induced arthritis mice by suppressing mitochondrial dysfunction and oxidative stress via the NRF2/HO-1/NQO1 signaling pathway. Pharmacological Research, 215, 107686. https://doi.org/10.1016/j.phrs.2025.107686

Vancouver

Guo WY, Wu QM, Zeng HF, Chen YL, Xu J, Yu ZY, et al. A sinomenine derivative alleviates bone destruction in collagen-induced arthritis mice by suppressing mitochondrial dysfunction and oxidative stress via the NRF2/HO-1/NQO1 signaling pathway. Pharmacological Research. 2025;215:107686. doi:10.1016/j.phrs.2025.107686

BibTeX
@article{Guo2025,
  author = {Guo, Wan-Yi and Wu, Qi-Min and Zeng, Hao-Feng and Chen, Yu-Lian and Xu, Jie and Yu, Zhen-Yi and Shu, Yong-Kang and Yang, Xiao-Nan and Zhang, Chuan-Hai and He, Xi-Zi and Mi, Jia-Ning and Chen, Si and Chen, Xiao-Man and Wu, Jia-Qi and Yao, He-Quan and Liu, Liang and Pan, Hu-Dan},
  title = {A sinomenine derivative alleviates bone destruction in collagen-induced arthritis mice by suppressing mitochondrial dysfunction and oxidative stress via the NRF2/HO-1/NQO1 signaling pathway},
  journal = {Pharmacological Research},
  year = {2025},
  volume = {215},
  pages = {107686},
  doi = {10.1016/j.phrs.2025.107686}
}
Kostenlos starten →